Investor Alert - TRTC Revenues Stock- Price !! INVESTOR

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Investor Alert - TRTC Revenues Stock- Price !!
INVESTOR ALARM ( Ver. Sept. 23rd )

Bio·Vegetable & Marijuana-Hemp & Green Tech - TRTC Terra Tech Corp. - USA
( Also Medical Field )

This as attempt for by mutual consent and systematical manner
All Here once to be Agree on same Revenues or Stock- Price
Estimate numbers, because everybody just coming- up with
something different is only causing confusions and really
nothing for the GOOD we need to Relay On !


1. Up-Front lets be Agree on the Stock EPS- Ratios & Earning Definition :
- Blue- Chips have an EPS- Ratio of 10 - 20x , OK !
- None Blue- Chips have an EPS- Ratio of 30 - 60x , OK !
- TRTC as No Blue- Chip to apply middle EPS- Ration of 45x !
- TRTC Stocks instead as Issued & Outstanding 88 Mn take 100 Mn !
( OTC Markets Registered Free- Floating Stocks of 48 Mn, same as 2012 )
- Revenue is Not Earning and Earning is the Margin Not Net- Income
and Net- Income Is after Deductions of Any Expenses from Earning
and before of Any Taxes !


2. For Annual Revenues & Earning to calculate we have TRTC Information’s as :

- 5-Acre Production Plant Revenue $ 10 Mn - we apply 9 Mn by Margin 40 % !
( This also as model to sell High- Tech Companies to US Farming Industry. )

- Contracts with NB Plants of 100% & GroRite of 50% From Its Productions !
NB & GroRite Contracts grant TRTC a Royalty of 10% from its Revenues,
the complain send TRTC to increase this to at least 20% since any Agency
Royalty Standards are between 30 - 60% depending on Items- Price Range.
Wondering when the Vande Vredes will be more reasonable to allow the
Royalty of 20%, but resulting we now need to calculate by 10% only.
From NB Plants is known Revenues $ 6 Mn and GroRite $ 4 Mn, by the
Contracts % Resulting to $ 8 Mn, but we take $ 7 Mn to calculate !

- We have now the Starting Q2 of 65 Days Edible Garden Corp. participation
resulting to $ 0,665 Mn, taking this for the Quarters of usually 90 Days
would result to $ 0,920 Mn, but until now we have no TRTC reply of why
its Estimate Q2 for 65 Days of $ 0,8 Mn was not achieved and therefore
it becomes difficult to use the numbers for calculations !
- Florida Project of Revenue $ 800,000 , where TRTC get a Royalty of 15%,
the complain for after the first Business- Year to increase this also to 20%
is made to TRTC, but since there is not yet any TRTC reconfirmation we
need to calculate this by the Royalty of 15% !

- For the Hydroponic Equipments & Accessories & Companies Sales
we have not any reliable Estimate Numbers and need to wait until
the next Version of Investors Presentation.
Therefore at the moment we cannot consider this !

- For TRTC’s Electricity Management Matter we have also No Numbers
until now and therefore cannot consider this !

This Above Points 1. and 2. As Calculation Basis !!


According to Above and to make it a little more simple,
the Calculation Estimates of Revenue, Earnings and
Stock- Price only as from 2014 :

- New 5-Acre Production Plant, Revenue $ 9 Mn, Earning $ 3,6 Mn !

- NB Plants & GroRite Contracts, Revenue $ 7 Mn, Earning $ 0,7 Mn !

- Florida Project, Revenue $ 0,8 Mn, Earning $ 0,12 Mn !
( Here Without New Such Projects TRTC Announced For US Wide ! )

- Hydroponic Equipments & Accessories & Complete Companies Sales also
under Contracts for Edible Garden Products as in Florida, here not considered !

- The TRTC’s Electricity Management Matter, here not considered !

( Here Without Any MJ or Hemp Growing Projects Soon Possible ! )

As Resulting :
2014 Revenue Estimate = $ 16,8 Mn
2014 Earning Estimate = $ 4,42 Mn

TRTC Stock- Price = $ 1,99 at for example 100 Mn Stocks by EPS- Ratio 45x !!
This within the first 6 Months of 2014, depending on TRTC Progress
Information’s and the resulting Investors Reactions !!

At during 2012 until Q1 2013, the Monthly Money Net- Loss
was at $ 0,5 Mn and this now by 50% Less has improved !.
At Same Rate TRTC Will Be Writing Black- Profit Numbers
Already As From Within November 2013 !!
3. If TRTC by the US Fed. would be allowed to grow MJ or TRTC does
Grow the Gene Manipulated CBD Hemp with ZERO THC as already by
the US Senate as Industrial Agricultural Product Is US Wide Legalized,
it compare the Bio·Vegetable & Herbs could provide a 7 - 10x Higher
Profit- Margin resulting the Stock- Price of $ 1,99 to increase 6 - 8x !!

To use possibly Morphine- Based Medication with Huge- Side- Effects only
for Last Days of Life, because CBD can replace over 90 % of Morphine
Pain- Therapy Applications, beside its potential to reduce Cancer, Etc. !
For TRTC because there is no other same US company existing it means
also, if GW Pharmaceuticals owned by the Big Companies Consortium of
worldwide annual Revenues $ 160 Bn is deciding to have Production of
CBD Sativex also in the US as well for Latin America Markets, it could by
TRTC in US get the Gene Manipulated CBD Hemp produced Hydroponically
Free Of Very Toxic Pesticides, instead now just everything Europe Made !!

Depending on US MJ Laws, TRTC has the Big Potential to become
„King of Marijuana“ because has the capacity to produce the MMJ
in the Best Med. Bio-Quality for the complete US Demand without
Very Toxic Pesticides as by any other much smaller producers !!
This By TRTC‘s Office for MJ & CBD Marketing In Washington !
At MJ or CBD Production Conditions it would mean if take above F.8x :
Earning $ 35,36 Mn = Stock- Price $ 15,92 / at OS of 100 Mn Stocks !!

To be conservative on the reliable save side, all considered Aspects
are by reductions applied or if at the moment not any reliable
numbers exist not even been considered !

Any other Facts or Experiences are Welcoming only !


Happy TRTC Investing


Technical’s :

September 20th ShortReport - 33,60 % Shorted Volume :
Weekly 5 Days Av. Short Volume 27,74 % !

September 20th AmericanBulls - BULLISH - Bullish Harami - IMO Sept. 23rd BUY !
( Its recommendations are always 1 Day too late, because
from the Day when the Stock Markets already closed
and News Events not considered by computer ! )

By Sierra World Equity Review
Rating : BUY - Short Term Target Price: $ 0,16 Within 10 Days !
Sept. 20th StockTA - TRTC Analysis & Charts Indicators. BULLISH - BULLISH ! :

TRTC Investors Advices - Trade Strategy !!


General :

TRTC Income Opportunities !!

TRTC Info Credibility Rating & Summary !!

TRTC & NASDAQ Conditions !!

TRTC Q2 Success Right On Track !!

INVESTOR ALERT - TRTC & Bayer Crop Science !!

TRTC Overview & Up- Dates !!


FINRA Original - Warns Investors of Marijuana Stock Scams
by Companies Not SEC Registered - Therefore Resulting As
Preferable Remains Only TRTC, CBIS, GWPH :

Herewith Invited all MJxA, ERxB, MDxX, Etc. to become Real SEC Certified TRTC Investors !!




.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 69

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 131

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 169

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 53

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 161

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Leech Tishman Expands Healthcare Practice with Nelson Hardiman

Updated Category News Views 79

Leech Tishman Expands Its Healthcare Practice with Major Addition Leech Tishman is making a significant move in its growth strategy by merging with the respected healthcare firm, Nelson Hardiman. This collaboration is set to enhance Leech Tishman’s footprint in the healthcare sector, especially in the Southern California region, as they prepare to operate under the name...

Continue Reading
Schouw & Co. Announces Success in Share Buy-Back Program

Updated Category News Views 105

Schouw & Co. Share Buy-Back Program Overview Schouw & Co., a notable player in the business landscape, has embarked on an impactful share buy-back program that began recently. This strategic move allows the company to purchase shares worth up to DKK 50 million over a designated time frame, from January 2 to March 31. Such initiatives reflect the company's commitment to...

Continue Reading
Earnings Season Set to Shape Market Dynamics Amid Tariffs

Updated Category News Views 150

Understanding Market Sentiment During Earnings Season The upcoming earnings season presents an opportunity for Wall Street to shift its attention from external geopolitical factors to the internal dynamics of corporate performance. As companies prepare to unveil their second-quarter earnings reports, a closer look at how tariffs could influence consumer spending and,...

Continue Reading
Josh Ruben Joins the Board of PetVivo Holdings to Drive Growth

Updated Category News Views 316

Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) has announced the addition of Josh Ruben to its Board of Directors. This news comes from the company's efforts to further establish itself within the biomedical device sector aimed at improving the quality of life for companion animals. Transformational Leadership...

Continue Reading
Innovative Portable Solar and Wind Generator Concept Unveiled

Updated Category News Views 120

Your Sustainable Charging Solution We live in a time where sustainable energy solutions are becoming more paramount, and the invention of a portable solar and wind-powered generator meets that demand head-on. The concept builds on the idea that everyone deserves access to clean energy alternatives, especially for charging electronic devices. The Vision Behind the...

Continue Reading